Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.

This event brings together senior stakeholders, researchers, and policymakers to explore how innovation can transform clinical trials- accelerating development, improving patient outcomes, and ensuring regulatory compliance through technology-driven solutions and collaborative frameworks.

Representing Richmond at CTIP

Dr Edward Jackson, Medical Director

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Digital transformation in clinical trials
  • AI and data-driven solutions for faster, safer studies
  • Patient engagement and diversity strategies
  • Regulatory frameworks for innovative trial models
  • Collaboration between sponsors, CROs, and regulators

Connect With Us

If you are attending Future of Clinical Trials 2026 and would like to explore partnership or innovation opportunities email us at:
📧 fasteranswers@richmondpharmacology.com

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event